← Back to Analyst Consensus 
DRMA Buy
Dermata Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 7
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 12, 2026 (17 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 21, 2025 | Maxim Group | maintain | Buy → Buy | $10 | 42% |
| May 21, 2025 | Maxim Group | maintain | Buy → Buy | $3 | 42% |
| Aug 21, 2024 | Maxim Group | maintain | Buy → Buy | $6 | 42% |
| Mar 23, 2023 | Maxim Group | maintain | — → Buy | $4 | 42% |
Price Target Trend
Apr 21, 2026 Latest: $4 Oct 24, 2026
EPS Estimates
0y $-2.17
Lo: $-2.17 Hi: $-2.17
1 analysts ▲1
+1y $-1.43
Lo: $-1.43 Hi: $-1.43
1 analysts ▲1
0q $-0.55
Lo: $-0.55 Hi: $-0.55
1 analysts ▲1
+1q $-0.46
Lo: $-0.46 Hi: $-0.46
1 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days